Skip to content

The microcirculation in the pathogenesis of organ failure in patients with acute heart failure.

The microcirculation in the pathogenesis of organ failure in patients with acute heart failure. - CARMICI - protocol B

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30972
Enrollment
100
Registered
2007-11-12
Start date
2007-11-12
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic shock severe heart failure

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age of 18 years or older. 2. Admitted with the diagnosis acute heart failure (criteria: see protocol).

Exclusion criteria

Exclusion criteria: 1. Pregnancy (results in an altered hemodynamic state). 2. Oral bleeding.

Design outcomes

Primary

MeasureTime frame
1. Microvascular flow index, as obtained by SDF imaging. 2. Daily SOFA scores, as a measure for (multiple) organ failure. 3. Survival.

Secondary

MeasureTime frame
Data collection: 1. Clinical: Gender, age, length, weight, body temperature, Glascow Coma Scale, APACHE IV score, SAPS II score, diuresis. 2. (Macro)Hemodynamics: Heart rate, arterial blood pressure, central venous pressure, cardiac output, pulmonary artery pressure, pulmonary wedge pressure. 3. Respiratory: Positive end expiratory pressure (PEEP), respiratory rate. 4. Laboratory: Arterial blood gas analysis (pH, PaCO2, PaO2, SaO2), central venous blood gas analysis (ScvO2, PvCO2), lactate, glucose, hemoglobin (Hb), hematocrit (Ht), urea, creatinin, thrombocytes, leukocyrtes, PT/APTT/ACT. 5. Oxygen delivery: DO2=CO*13.4*[Hb]*SaO2. 6. Oxygen uptake: VO2=CO*13.4*Hb*(SaO2-SvO2).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)